# Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

> **NCT01047995** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 26 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Raltegravir plus Darunavir/ritonavir
- **DRUG:** Raltegravir plus Darunavir/ritonavir

## Key facts

- **NCT ID:** NCT01047995
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01047995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01047995, "Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01047995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*